Newly developed ChiTaRS database can collect cases of druggable fusion targets

When sections from two separate genes merge due to various factors, such as translocation or splicing, the hybrid that is formed is called a gene fusion. In recent years, it has been discovered that these fusion events play a vital role in the development of cancers and other complex diseases. However, there are very few resources which collate all this information and make it available in one place. By analysing over a million nucleic acid sequences from publicly available data, a team led by Dr. Milana Frenkel-Morgenstern, of the Azrieli Faculty of Medicine at Bar-Ilan University, has identified 111,582 fusions in eight species (human, mouse, rat, fruit-fly, wild boar, zebrafish, yeast and cattle).

The latest and most up-to-date version of this database, known as ChiTaRS, has just been published in the scientific journal Nucleic Acids Research. This database is being maintained currently by the Laboratory of Cancer Genomics and Biocomputing of Complex Diseases at the Azrieli Faculty of Medicine in Safed and will be extremely useful to clinicians specializing in complex diseases, particularly, cancers, Alzheimer's disease, schizophrenia and many others.

This edition of ChiTaRS collects cases of druggable fusion targets. In recent years, many of these fusion genes have served as specific targets, particularly for chemotherapy drugs. Some commonly known examples include the BCR-ABL1 fusion in chronic myeloid leukaemia (CML) and the EML4-ALK chimera in non-small cell lung cancer (NSCLC). ChiTaRS 5.0 provides a list of more than 800 druggable fusions, being used as targets by close to 120 drug or drug combinations, that are useful for personalised therapy in complex diseases.

This resource will be a boon to researchers working on identifying the functional role of chimeras/fusions in carcinogenesis. It will also be advantageous in the fields of 3D chromatin maps and evolutionary biology, among others. This is a new updated resource for Prof. Frenkel-Morgenstern's research group, which already maintains online resources like a server for text-mining of fusions (ProtFus) and protein-protein interactions of fusions (ChiPPI).

Source:
Journal reference:

Balamurali, D. et al. (2019) ChiTaRS 5.0: the comprehensive database of chimeric transcripts matched with druggable fusions and 3D chromatin maps. Nucleic Acids Research. doi.org/10.1093/nar/gkz1025

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover why the TP53 gene is especially prone to mutations in cancer